Fasting plasma glucose variability and all-cause mortality among type 2 diabetes patients: a dynamic cohort study in Shanghai, China

被引:40
作者
Xu, Dongli [1 ]
Fang, Hong [1 ]
Xu, Wanghong [2 ,3 ]
Yan, Yujie [1 ]
Liu, Yinan [1 ]
Yao, Baodong [1 ]
机构
[1] Shanghai Minhang Ctr Dis Control & Prevent, Shanghai, Peoples R China
[2] Fudan Univ, Dept Epidemiol, Sch Publ Hlth, Shanghai, Peoples R China
[3] Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Shanghai, Peoples R China
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
关键词
GLYCEMIC VARIABILITY; CANCER INCIDENCE; MELLITUS; RISK; COMPLICATIONS; PRESSURE; WEIGHT; STROKE;
D O I
10.1038/srep39633
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The study aims to examine whether the variation of fasting plasma glucose (FPG), represented by coefficient of variation (CV), independently predicts all-cause mortality among Chinese type 2 diabetes patients. This retrospective cohort study was designed based on a standardized electronic management system of diabetes patients in Shanghai, China. 8871 type 2 diabetes patients were enrolled between 1 January 2007 and 31 December 2007 and were followed-up for all-cause mortality until 31 December 2014. All patients were grouped by the quartiles of CV of FPG. 1136 patients deceased during following-up. After adjusting for other risk factors, CV of FPG was not independently associated with all-cause mortality. Stratified analysis by mean FPG levels (< 7 mmol/L and >= 7 mmol/L) observed a significant modifying effect of CV of FPG (P for interact test < 0.01). CV of FPG was independently associated with all-cause mortality in patients whose glucose control was poor, with the HRs (95% CI) for the second, third, fourth vs first quartiles of CV of FPG being 1.23(0.94-1.61), 1.23(0.94-1.61), and 1.63(1.25-2.13), respectively. Our results suggest that variability of FPG may be an important predictor of mortality among type 2 diabetes in China, particularly for those with their glycemic status uncontrolled.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Erythropoietin (EPO) haplotype associated with all-cause mortality in a cohort of Italian patients with Type-2 Diabetes
    Montesanto, Alberto
    Bonfigli, Anna Rita
    De Luca, Maria
    Crocco, Paolina
    Garagnani, Paolo
    Marasco, Elena
    Pirazzini, Chiara
    Giuliani, Cristina
    Romagnoli, Fabio
    Franceschi, Claudio
    Passarino, Giuseppe
    Testa, Roberto
    Olivieri, Fabiola
    Rose, Giuseppina
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [22] Impaired Fasting Plasma Glucose and Type 2 Diabetes Are Related to the Risk of Out-of-Hospital Sudden Cardiac Death and All-Cause Mortality
    Laukkanen, Jari A.
    Makikallio, Timo H.
    Ronkainen, Kimmo
    Karppi, Jouni
    Kurl, Sudhir
    [J]. DIABETES CARE, 2013, 36 (05) : 1166 - 1171
  • [23] Association of fasting blood glucose variability with all-cause mortality in heart transplant recipients
    Zheng, Qiang
    Liu, Xing
    Lan, Hongwen
    Guo, Qiannan
    Xiong, Tixiusi
    Wang, Kan
    Jiang, Chen
    Zhang, Jing
    Wang, Guohua
    Dong, Nianguo
    Shi, Jiawei
    [J]. CLINICAL TRANSPLANTATION, 2023, 37 (08)
  • [24] Association between fasting glucose and all-cause mortality according to sex and age: a prospective cohort study
    Yi, Sang-Wook
    Park, Sangkyu
    Lee, Yong-ho
    Park, Hyang-Jeong
    Balkau, Beverley
    Yi, Jee-Jeon
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [25] Racial Disparities in All-Cause Mortality Among Veterans with Type 2 Diabetes
    Lynch, Cheryl P.
    Gebregziabher, Mulugeta
    Echols, Carrae
    Gilbert, Gregory E.
    Zhao, Yumin
    Egede, Leonard E.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2010, 25 (10) : 1051 - 1056
  • [26] Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes
    Orsi, Emanuela
    Solini, Anna
    Bonora, Enzo
    Fondelli, Cecilia
    Trevisan, Roberto
    Vedovato, Monica
    Cavalot, Franco
    Gruden, Gabriella
    Morano, Susanna
    Nicolucci, Antonio
    Penno, Giuseppe
    Pugliese, Giuseppe
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (08) : 1885 - 1893
  • [27] A synergistic effect of variability in estimated glomerular filtration rate with chronic kidney disease on all-cause mortality prediction in patients with type 2 diabetes: a retrospective cohort study
    Chang, Yu-Shan
    Li, Yu-Hsuan
    Lee, I-Te
    [J]. CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [28] Body mass index and risk of all-cause mortality with normoglycemia, impaired fasting glucose and prevalent diabetes: results from the Rural Chinese Cohort Study
    Zhao, Yang
    Liu, Yu
    Sun, Haohang
    Sun, Xizhuo
    Yin, Zhaoxia
    Li, Honghui
    Ren, Yongcheng
    Wang, Bingyuan
    Zhang, Dongdong
    Liu, Xuejiao
    Liu, Dechen
    Zhang, Ruiyuan
    Liu, Feiyan
    Chen, Xu
    Liu, Leilei
    Cheng, Cheng
    Zhou, Qionggui
    Hu, Dongsheng
    Zhang, Ming
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2018, 72 (11) : 1052 - 1058
  • [29] Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study
    Penno, Giuseppe
    Solini, Anna
    Orsi, Emanuela
    Bonora, Enzo
    Fondelli, Cecilia
    Trevisan, Roberto
    Vedovato, Monica
    Cavalot, Franco
    Zerbini, Gianpaolo
    Lamacchia, Olga
    Nicolucci, Antonio
    Pugliese, Giuseppe
    [J]. BMC MEDICINE, 2021, 19 (01)
  • [30] A comparison of all-cause mortality with pioglitazone and insulin in type 2 diabetes: an expanded analysis from a retrospective cohort study
    Yang, Jiao
    Vallarino, Carlos
    Bron, Morgan
    Perez, Alfonso
    Liang, Huifang
    Joseph, Guiandre
    Yu, Shawn
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (11) : 2223 - 2231